Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Anna Bowzyk Al-Naeeb"'
Autor:
Amarnath Challapalli, Emily Renninson, Paul White, Thiraviyam Elumalai, Omi Parikh, Alexander Vickers, Alison Jane Birtle, Andrew Brocklehurst, Rajanee Bhana, Kanchana Wickramasinghe, Kamalram Thippu Jayaprakash, Emma Gray, Matthew Sephton, Anna Bowzyk Al-Naeeb, Emily Foulstone, Alexandra Soundy, Lauren Ashurst, Amit Bahl
Publikováno v:
Journal of Clinical Oncology. 41:335-335
335 Background: The RECORD Study is a real world data, prospective evaluation of clinical outcomes in patients with nmCRPC treated with Darolutamide. This study will increase the understanding of treatment response and management and in particular in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f76dcee2b0e3a07fce0029e17b2584a2
https://doi.org/10.1200/jco.2023.41.6_suppl.335
https://doi.org/10.1200/jco.2023.41.6_suppl.335
Autor:
Sean H. Lim, Nicola Campbell, Beth Stuart, Marina Johnson, Debora Joseph-Pietras, Adam Kelly, Danielle Jeffrey, Anna H. Turaj, Kate Rolfvondenbaumen, Celine Galloway, Thomas Wynn, Adam R. Coleman, Benjamin Ward, Karen Long, Andrew T. Bates, Diana Ayres, Robert Lown, Janlyn Falconer, Oliver Brake, James Batchelor, Victoria Willimott, Anna Bowzyk Al-Naeeb, Lisa Robinson, Ann O’Callaghan, Graham P. Collins, Tobias Menne, Saul N. Faust, Christopher P. Fox, Matthew Ahearne, Peter W.M. Johnson, Andrew J. Davies, David Goldblatt
SUMMARYSARS-CoV-2 vaccination protects against COVID-19. Antibodies and antigen-specific T-cell responses against the spike domain can be used to measure vaccine immune response. Individuals with lymphoma have defects in humoral and cellular immunity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05db81c23d3f376117b26a44fb620057
https://doi.org/10.1101/2021.12.08.21266760
https://doi.org/10.1101/2021.12.08.21266760
Autor:
Sean H. Lim, Beth Stuart, Debora Joseph-Pietras, Marina Johnson, Nicola Campbell, Adam Kelly, Danielle Jeffrey, Anna H. Turaj, Kate Rolfvondenbaumen, Celine Galloway, Thomas Wynn, Adam R. Coleman, Benjamin Ward, Karen Long, Helen Coleman, Carina Mundy, Andrew T. Bates, Diana Ayres, Robert Lown, Janlyn Falconer, Oliver Brake, James Batchelor, Victoria Willimott, Anna Bowzyk Al-Naeeb, Lisa Robinson, Ann O’Callaghan, Graham P. Collins, Tobias Menne, Saul N. Faust, Christopher P. Fox, Matthew Ahearne, Peter W. M. Johnson, Andrew J. Davies, David Goldblatt
Publikováno v:
Nature cancer. 3(5)
Patients with hematological malignancies are at increased risk of severe COVID-19 outcomes due to compromised immune responses, but the insights of these studies have been compromised due to intrinsic limitations in study design. Here we present the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e506cf0e53293f76d17683e1486ea5c1
https://pubmed.ncbi.nlm.nih.gov/35624336
https://pubmed.ncbi.nlm.nih.gov/35624336
Publikováno v:
Kidney Cancer. 2:103-113
Background: The use of conventionally fractionated intensity modulated radiotherapy (IMRT) in the management of oligometastatic renal cell carcinoma (RCC) is currently poorly characterised in the literature. Objective: To evaluate the safety and effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d22ced9267526b5c0195d7e88e7a5e1
https://doi.org/10.3233/kca-170025
https://doi.org/10.3233/kca-170025
Publikováno v:
BMJ. :k3204
What you need to know Non-Hodgkin lymphoma are malignant disorders arising from cells of the immune system, and manifest predominantly as lymphadenopathy or solid tumours. The classification of non-Hodgkin lymphoma is complex and ever-evolving, with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e432afff36f8f350ff1ec6cb68ce2d5a
https://doi.org/10.1136/bmj.k3204
https://doi.org/10.1136/bmj.k3204
Publikováno v:
Neuro-Oncology. 18:iii98.3-iii98
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88c809a0075a2fed5785eff6c01438eb
https://doi.org/10.1093/neuonc/now076.07
https://doi.org/10.1093/neuonc/now076.07
Publikováno v:
Journal of Clinical Oncology. 32:439-439
439 Background: Anal cancer, a tumour induced by the human papilloma virus (HPV) is highly responsive to chemoradiation. Smoking appears to be an important cofactor in its development, possibly through immunomodulatory mechanism and has been reported
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fae6ae4f0c0907c3f300e7a8006fe6f9
https://doi.org/10.1200/jco.2014.32.3_suppl.439
https://doi.org/10.1200/jco.2014.32.3_suppl.439